<--- Back to Details
First PageDocument Content
Entertainment / Drug culture / Culture / Euphoriants / Rave / Amphetamines / Club drug / MDMA / Acid house / Dance / Parties / Electronic music
Date: 2008-01-28 12:10:01
Entertainment
Drug culture
Culture
Euphoriants
Rave
Amphetamines
Club drug
MDMA
Acid house
Dance
Parties
Electronic music

Product No[removed]L0424-004 BULLETIN INFORMATION APRIL 2001

Add to Reading List

Source URL: www.popcenter.org

Download Document from Source Website

File Size: 696,99 KB

Share Document on Facebook

Similar Documents

The PROFILE®-III/VERDICT®-III products are one-step qualitative screening assays for the detection of one or more of the following:   Amphetamines, Barbiturates, Benzodiazepines, Cocaine, Methamphetamine/ 3,4 Methylene

The PROFILE®-III/VERDICT®-III products are one-step qualitative screening assays for the detection of one or more of the following: Amphetamines, Barbiturates, Benzodiazepines, Cocaine, Methamphetamine/ 3,4 Methylene

DocID: 1vbZz - View Document

The PROFILE®-III/VERDICT®-III products are one-step qualitative screening assays for the detection of one or more of the following:   Amphetamines, Barbiturates, Benzodiazepines, Cocaine, Methamphetamine/ 3,4 Methylene

The PROFILE®-III/VERDICT®-III products are one-step qualitative screening assays for the detection of one or more of the following: Amphetamines, Barbiturates, Benzodiazepines, Cocaine, Methamphetamine/ 3,4 Methylene

DocID: 1uR19 - View Document

Brit. J. Pharmacol), 24, DIFFERENTIAL EFFECTS OF TWO AMPHETAMINEBARBITURATE MIXTURES IN MAN BY  D. W. DICKINS*, M. H. LADERt AND HANNAH STEINBERG

Brit. J. Pharmacol), 24, DIFFERENTIAL EFFECTS OF TWO AMPHETAMINEBARBITURATE MIXTURES IN MAN BY D. W. DICKINS*, M. H. LADERt AND HANNAH STEINBERG

DocID: 1s1P0 - View Document

4  PHARMACOLOGIC TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) IN ADULTS

4 PHARMACOLOGIC TREATMENT OF ATTENTION DEFICIT HYPERACTIVITY DISORDER (ADHD) IN ADULTS

DocID: 1r9hg - View Document

New Drugs Approved in FY 2015 Review Category Approval Date No.

New Drugs Approved in FY 2015 Review Category Approval Date No.

DocID: 1r3Vv - View Document